Evidence map›Paper›PMID 37033681›Full record

ArticleWorld journal of cardiology2023

Real-world five-year outcomes of FlexyRap

Nitish Garg, Raman Chawla, Vivek Tandon, Deepak Garg, Nilesh Parshottam, Preeti Vani, Malte Neuss

Abstract read
In one paragraph

Article in World journal of cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nitish GargDepartment of Interventional Cardiology, Cardinova Hospital, Jalandhar 144001, India.
Raman ChawlaDepartment of Interventional Cardiology, CareMax Hospital, Jalandhar 144001, India.
Vivek TandonDepartment of Interventional Cardiology, EMC Hospital, Amritsar 143001, India.
Deepak GargDepartment of Interventional Cardiology, Moga Medicity Hospital, Moga 142001, India.
Nilesh ParshottamDepartment of Interventional Cardiology, Sunshine Global Hospital, Surat 394370, India.
Preeti VaniMedical Division, Sahajanand Laser Technology Ltd., Gandhinagar, Gujarat, 382028, India. clinical@sltl.com.
Malte NeussMedical Division, Sahajanand Laser Technology Ltd., Gandhinagar, Gujarat, 382028, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe use of biodegradable polymer drug-eluting stents (BP-DES) has been proven to minimize restenosis and stent thrombosis. The current post-marketing monitoring was observed at the 5-year clinical outcomes of individuals who had been treated with FlexyRap

aimTo assess the safety and effectiveness of FlexyRap

methodsFindings from a retrospective, multi-center, observational, post-market clinical follow-up study of patients treated with FlexyRap

resultsThe data of 500 patients received with FlexyRap

conclusionFlexyRap

Indexed as

Coronary artery diseaseDrug-eluting stentsPercutaneous coronary interventionRapamycinSirolimus

Identifiers

PMID37033681
PMCPMC10074995

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.